CIVIL ENGINEERING 365 ALL ABOUT CIVIL ENGINEERING


  • 1.

    Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 1977;50:481–92.

    CAS 
    Article 

    Google Scholar
     

  • 2.

    Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA. 1980;77:7415–9.

    CAS 
    Article 

    Google Scholar
     

  • 3.

    Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita KI, et al. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA. 1981;78:6476–80.

    CAS 
    Article 

    Google Scholar
     

  • 4.

    Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984–87). Br J Haematol. 1991;79:428–37.

    CAS 
    Article 

    Google Scholar
     

  • 5.

    Katsuya H, Ishitsuka K, Utsunomiya A, Hanada S, Eto T, Moriuchi Y, et al. Treatment and survival among 1594 patients with ATL. Blood. 2015;126:2570–7.

    CAS 
    Article 

    Google Scholar
     

  • 6.

    Yamada Y, Kamihira S, Murata K, Yamamura M, Maeda T, Tsukasaki K, et al. Frequent hepatic involvement in adult T cell leukemia: comparison with non-Hodgkin’s lymphoma. Leuk Lymphoma. 1997;26:327–35.

    CAS 
    Article 

    Google Scholar
     

  • 7.

    Yoshie O, Fujisawa R, Nakayama T, Harasawa H, Tago H, Izawa D, et al. Frequent expression of CCR4 in adult T-cell leukemia and human T-cell leukemia virus type 1-transformed T cells. Blood. 2002;99:1505–11.

    CAS 
    Article 

    Google Scholar
     

  • 8.

    Hieshima K, Nagakubo D, Nakayama T, Shirakawa AK, Jin Z, Yoshie O. Tax-inducible production of CC chemokine ligand 22 by human T cell leukemia virus type 1 (HTLV-1)-infected T cells promotes preferential transmission of HTLV-1 to CCR4-expressing CD4+ T cells. J Immunol. 2008;180:931–9.

    CAS 
    Article 

    Google Scholar
     

  • 9.

    Ishida T, Joh T, Uike N, Yamamoto K, Utsunomiya A, Yoshida S, et al. Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study. J Clin Oncol. 2012;30:837–42.

    CAS 
    Article 

    Google Scholar
     

  • 10.

    Ishida T, Jo T, Takemoto S, Suzushima H, Uozumi K, Yamamoto K, et al. Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study. Br J Haematol. 2015;169:672–82.

    CAS 
    Article 

    Google Scholar
     

  • 11.

    Ishida T, Utsunomiya A, Jo T, Yamamoto K, Kato K, Yoshida S, et al. Mogamulizumab for relapsed adult T-cell leukemia-lymphoma: updated follow-up analysis of phase I and II studies. Cancer Sci. 2017;108:2022–9.

    CAS 
    Article 

    Google Scholar
     

  • 12.

    Umino A, Nakagawa M, Utsunomiya A, Tsukasaki K, Taira N, Katayama N, et al. Clonal evolution of adult T-cell leukemia/lymphoma takes place in the lymph nodes. Blood. 2011;117:5473–8.

    CAS 
    Article 

    Google Scholar
     

  • 13.

    Kataoka K, Nagata Y, Kitanaka A, Shiraishi Y, Shimamura T, Yasunaga J, et al. Integrated molecular analysis of adult T cell leukemia/lymphoma. Nat Genet. 2015;47:1304–15.

    CAS 
    Article 

    Google Scholar
     

  • 14.

    Yamagishi M, Nakano K, Miyake A, Yamochi T, Kagami Y, Tsutsumi A, et al. Polycomb-mediated loss of miR-31 activates NIK-dependent NF-kappaB pathway in adult T cell leukemia and other cancers. Cancer Cell. 2012;21:121–35.

    CAS 
    Article 

    Google Scholar
     

  • 15.

    Fujikawa D, Nakagawa S, Hori M, Kurokawa N, Soejima A, Nakano K, et al. Polycomb-dependent epigenetic landscape in adult T-cell leukemia. Blood. 2016;127:1790–802.

    CAS 
    Article 

    Google Scholar
     

  • 16.

    Yamagishi M, Hori M, Fujikawa D, Ohsugi T, Honma D, Adachi N, et al. Targeting excessive EZH1 and EZH2 activities for abnormal histone methylation and transcription network in malignant lymphomas. Cell Rep. 2019;29:2321–37.e2327.

    CAS 
    Article 

    Google Scholar
     

  • 17.

    Ding X, Ji J, Jiang J, Cai Q, Wang C, Shi M, et al. HGF-mediated crosstalk between cancer-associated fibroblasts and MET-unamplified gastric cancer cells activates coordinated tumorigenesis and metastasis. Cell Death Dis. 2018;9:867.

    Article 

    Google Scholar
     

  • 18.

    Hartmann S, Bhola NE, Grandis JR. HGF/Met signaling in head and neck cancer: impact on the tumor microenvironment. Clin Cancer Res. 2016;22:4005–13.

    CAS 
    Article 

    Google Scholar
     

  • 19.

    Kwon Y, Smith BD, Zhou Y, Kaufman MD, Godwin AK. Effective inhibition of c-MET-mediated signaling, growth and migration of ovarian cancer cells is influenced by the ovarian tissue microenvironment. Oncogene. 2015;34:144–53.

    CAS 
    Article 

    Google Scholar
     

  • 20.

    Choi YL, Tsukasaki K, O’Neill MC, Yamada Y, Onimaru Y, Matsumoto K, et al. A genomic analysis of adult T-cell leukemia. Oncogene. 2007;26:1245–55.

    CAS 
    Article 

    Google Scholar
     

  • 21.

    Imaizumi Y, Murota H, Kanda S, Hishikawa Y, Koji T, Taguchi T, et al. Expression of the c-Met proto-oncogene and its possible involvement in liver invasion in adult T-cell leukemia. Clin Cancer Res. 2003;9:181–7.

    CAS 
    PubMed 

    Google Scholar
     

  • 22.

    Onimaru Y, Tsukasaki K, Murata K, Imaizumi Y, Choi YL, Hasegawa H, et al. Autocrine and/or paracrine growth of aggressive ATLL cells caused by HGF and c-Met. Int J Oncol. 2008;33:697–703.

    CAS 
    PubMed 

    Google Scholar
     

  • 23.

    Oki S, Ohta T, Shioi G, Hatanaka H, Ogasawara O, Okuda Y, et al. ChIP-Atlas: a data-mining suite powered by full integration of public ChIP-seq data. EMBO Rep. 2018;19:e46255.

    Article 

    Google Scholar
     

  • 24.

    Oshiro A, Tagawa H, Ohshima K, Karube K, Uike N, Tashiro Y, et al. Identification of subtype-specific genomic alterations in aggressive adult T-cell leukemia/lymphoma. Blood. 2006;107:4500–7.

    CAS 
    Article 

    Google Scholar
     

  • 25.

    Piekarz RL, Frye R, Turner M, Wright JJ, Allen SL, Kirschbaum MH, et al. Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma. J Clin Oncol. 2009;27:5410–7.

    CAS 
    Article 

    Google Scholar
     

  • 26.

    Piekarz RL, Frye R, Prince HM, Kirschbaum MH, Zain J, Allen SL, et al. Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma. Blood. 2011;117:5827–34.

    CAS 
    Article 

    Google Scholar
     

  • 27.

    Olsen EA, Kim YH, Kuzel TM, Pacheco TR, Foss FM, Parker S, et al. Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma. J Clin Oncol. 2007;25:3109–15.

    CAS 
    Article 

    Google Scholar
     

  • 28.

    Nakagawa M, Shaffer AL 3rd, Ceribelli M, Zhang M, Wright G, Huang DW, et al. Targeting the HTLV-I-regulated BATF3/IRF4 transcriptional network in adult T Cell Leukemia/Lymphoma. Cancer Cell. 2018;34:286–297.e210.

    CAS 
    Article 

    Google Scholar
     

  • 29.

    Rutella S, Bonanno G, Procoli A, Mariotti A, de Ritis DG, Curti A, et al. Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10++IL-12low/neg accessory cells with dendritic-cell features. Blood. 2006;108:218–27.

    CAS 
    Article 

    Google Scholar
     

  • 30.

    Bonanno G, Mariotti A, Procoli A, Folgiero V, Natale D, De Rosa L, et al. Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma. J Transl Med. 2012;10:247.

    CAS 
    Article 

    Google Scholar
     

  • 31.

    Masaki A, Ishida T, Maeda Y, Suzuki S, Ito A, Takino H, et al. Prognostic significance of tryptophan catabolism in adult T-cell Leukemia/Lymphoma. Clin Cancer Res. 2015;21:2830–9.

    CAS 
    Article 

    Google Scholar
     

  • 32.

    Skibinski G, Skibinska A, James K. Hepatocyte growth factor (HGF) protects c-met-expressing Burkitt’s lymphoma cell lines from apoptotic death induced by DNA damaging agents. Eur J Cancer. 2001;37:1562–9.

    CAS 
    Article 

    Google Scholar
     

  • 33.

    Miyoshi I, Kubonishi I, Sumida M, Hiraki S, Tsubota T, Kimura I, et al. A novel T-cell line derived from adult T-cell leukemia. Gan. 1980;71:155–6.

    CAS 
    PubMed 

    Google Scholar
     

  • 34.

    Sugamura K, Fujii M, Kannagi M, Sakitani M, Takeuchi M, Hinuma Y. Cell surface phenotypes and expression of viral antigens of various human cell lines carrying human T-cell leukemia virus. Int J Cancer. 1984;34:221–8.

    CAS 
    Article 

    Google Scholar
     

  • 35.

    Naoe T, Akao Y, Yamada K, Utsumi KR, Koike K, Shamoto M, et al. Cytogenetic characterization of a T-cell line, ATN-1, derived from adult T-cell leukemia cells. Cancer Genet Cytogenet. 1988;34:77–88.

    CAS 
    Article 

    Google Scholar
     

  • 36.

    Suzuki S, Masaki A, Ishida T, Ito A, Mori F, Sato F, et al. Tax is a potential molecular target for immunotherapy of adult T-cell leukemia/lymphoma. Cancer Sci. 2012;103:1764–73.

    CAS 
    Article 

    Google Scholar
     

  • 37.

    Xu C, Plattel W, van den Berg A, Ruther N, Huang X, Wang M, et al. Expression of the c-Met oncogene by tumor cells predicts a favorable outcome in classical Hodgkin’s lymphoma. Haematologica. 2012;97:572–8.

    CAS 
    Article 

    Google Scholar
     

  • 38.

    Murashima A, Shinjo K, Katsushima K, Onuki T, Kondoh Y, Osada H, et al. Identification of a chemical modulator of EZH2-mediated silencing by cell-based high-throughput screening assay. J Biochem. 2019;166:41–50.

    CAS 
    Article 

    Google Scholar
     



  • Source link

    Leave a Reply

    Your email address will not be published. Required fields are marked *